Overview
Generare Bioscience SAS, a Paris-based biotechnology company, has raised €20 million (approximately $23.3 million) in an early-stage funding round co-led by Alven and Daphni. The funding aims to support the company's innovative approach to generating molecular data for drug development using artificial intelligence. Existing investors, including Galion.exe, Teampact Ventures, and Vives Partners, also participated in this Series A round.
Products
Loading...
Recent Deals
Investors: Alven, Daphni, Galion.exe, Teampact Ventures, Vives Partners
Generare Bioscience SAS, a Paris-based biotechnology company, has raised €20 million (approximately $23.3 million) in an early-stage funding round co-led by Alven and Daphni. The funding aims to support the company's innovative approach to generating molecular data for drug development using artificial intelligence. Existing investors, including Galion.exe, Teampact Ventures, and Vives Partners, also participated in this Series A round.